Last update 08 May 2025

Suzhou Zerun Biotechnology Co., Ltd.

Private Company|2019|Jiangsu Sheng, China

Overview

Tags

Neoplasms
Skin and Musculoskeletal Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
PI3Kα x mTORC1 x mTORC21

Related

1
Drugs associated with Suzhou Zerun Biotechnology Co., Ltd.
YS-001
Target
PI3Kα x mTORC1 x mTORC2
Mechanism
PI3Kα inhibitors [+2]
Active Org.
Suzhou Zerun Biotechnology Co., Ltd. [+1]
Originator Org.
Jiangsu Wuzhong Medicine Group Co., Ltd.Jiangsu Wuzhong Medicine Group Co., Ltd.
Active Indication
Advanced Malignant Solid Neoplasm [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Suzhou Zerun Biotechnology Co., Ltd.
CTR20212794
/ RecruitingPhase 1
YS001胶囊治疗晚期恶性实体瘤患者的开放标签、多中心、剂量递增和扩展I期临床试验
[Translation] An open-label, multicenter, dose-escalation and expansion phase I clinical trial of YS001 capsules in patients with advanced malignant solid tumors
100 Clinical Results associated with Suzhou Zerun Biotechnology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Suzhou Zerun Biotechnology Co., Ltd.
Login to view more data
100 Deals associated with Suzhou Zerun Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Suzhou Zerun Biotechnology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 Oct 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
YS-001
 ( PI3Kα x mTORC1 x mTORC2 )		Advanced Malignant Solid Neoplasm
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free